Xu, J., Tang, W., Yang, X., Yang, Y., Chen, Q., Cheng, J., Wan, X., Song, Y., Li, M. (2025). A phase II, randomized study of JMT101 in combination with irinotecan and SG001 versus regorafenib in patients with metastatic colorectal adenocarcinoma (mCRC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.tps314